N-[(2-aminocyclopropyl)methyl]-4-[[3-[1-cyclobutyl-3-(trifluoromethyl)pyrazol-4-yl]imidazo[1,2-a]pyrazin-8-yl]amino]-2-ethylbenzamide
C27H29F3N8O — CID 157025365
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(2-aminocyclopropyl)methyl]-4-[[3-[1-cyclobutyl-3-(trifluoromethyl)pyrazol-4-yl]imidazo[1,2-a]pyrazin-8-yl]amino]-2-ethylbenzamide
N-[(2-aminocyclopropyl)methyl]-4-[[3-[1-cyclobutyl-3-(trifluoromethyl)pyrazol-4-yl]imidazo[1,2-a]pyrazin-8-yl]amino]-2-ethylbenzamide (PubChem CID 157025365) has the molecular formula C27H29F3N8O and a molecular weight of 538.58 g/mol. Its IUPAC name is N-[(2-aminocyclopropyl)methyl]-4-[[3-[1-cyclobutyl-3-(trifluoromethyl)pyrazol-4-yl]imidazo[1,2-a]pyrazin-8-yl]amino]-2-ethylbenzamide.
Molecular Properties
| Compound Name | N-[(2-aminocyclopropyl)methyl]-4-[[3-[1-cyclobutyl-3-(trifluoromethyl)pyrazol-4-yl]imidazo[1,2-a]pyrazin-8-yl]amino]-2-ethylbenzamide |
|---|---|
| PubChem CID | 157025365 |
| Molecular Formula | C27H29F3N8O |
| Molecular Weight | 538.58 g/mol |
| Exact Mass | 538.24 |
| IUPAC Name | N-[(2-aminocyclopropyl)methyl]-4-[[3-[1-cyclobutyl-3-(trifluoromethyl)pyrazol-4-yl]imidazo[1,2-a]pyrazin-8-yl]amino]-2-ethylbenzamide |
| SMILES | CCc1cc(Nc2nccn3c(-c4cn(C5CCC5)nc4C(F)(F)F)cnc23)ccc1C(=O)NCC1CC1N |
| InChI | InChI=1S/C27H29F3N8O/c1-2-15-10-17(6-7-19(15)26(39)34-12-16-11-21(16)31)35-24-25-33-13-22(37(25)9-8-32-24)20-14-38(18-4-3-5-18)36-23(20)27(28,29)30/h6-10,13-14,16,18,21H,2-5,11-12,31H2,1H3,(H,32,35)(H,34,39) |
| InChIKey | OXXZQTACSPNYGA-UHFFFAOYSA-N |
| XLogP | 4.72 |
| TPSA | 115.16 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 538.58 |
| LogP ≤ 5 | 4.72 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157025365 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.